Cai Zhonglin, Song Xiaoqing, Zhang Jianzhong, Yang Bin, Li Hongjun
1Department of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
2Department of Pathology, First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
Aging Dis. 2020 Oct 1;11(5):1202-1218. doi: 10.14336/AD.2019.1028. eCollection 2020 Oct.
Erectile dysfunction (ED) is a common sexual disorder in adult males and one of the most important factors affecting their quality of life and that of their partners. Although PDE5 inhibitors (PDE5is) are the first choice for improving erectile function, there is a substantial proportion of ED patients, termed PDE5i nonresponders, who do not respond to PDE5is. Because of the lack of effective therapies, these patients always have serious social and psychological problems due to ED, which should be addressed. Here, we review the available literature about ED and PDE5is and propose several strategies for mitigating ED in PDE5i nonresponders.
勃起功能障碍(ED)是成年男性常见的性功能障碍,也是影响其自身及伴侣生活质量的最重要因素之一。尽管5型磷酸二酯酶抑制剂(PDE5is)是改善勃起功能的首选药物,但仍有相当一部分ED患者,即PDE5i无反应者,对PDE5is没有反应。由于缺乏有效的治疗方法,这些患者因ED往往存在严重的社会和心理问题,亟待解决。在此,我们回顾了有关ED和PDE5is的现有文献,并提出了几种减轻PDE5i无反应者ED症状的策略。